Healthcare · Pharmaceutical spending per capita
Canada is among the top five global leaders in per capita pharmaceutical spending, reaching 950 $ in 2026. This high expenditure is driven by the cost of innovative drugs, widespread private insurance coverage, and an aging population. The bulk of sales occurs through pharmacy chains in Ontario and Quebec, home to a third of all Canadians. In 2026, Canada ranks 5-th out of 197, highlighting the size and high monetization of its national pharmaceutical market.
Data for 2026 · unit: $
Position
#5 / 197
Canada world ranking
Country position on the scale from last to first place for this indicator.
CA
#5
#197#1
Trend
Change over time
Change in indicator over the available period.
350
1990
550
2000
750
2010
900
2020
950
2026
Values — $
Comparison
Top countries by Pharmaceutical spending per capita
Where Canada stands in the world ranking.
1
MCMonaco
1.9 K
2
USUSA
1.4 K
3
LILiechtenstein
1.3 K
4
LULuxembourg
1.2 K
5
JPJapan
950
5
CACanada
950
7
CHSwitzerland
920
8
SMSan Marino
850
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical spending per capita in Canada — how much?
Based on 2026 data — 950 $. This is rank #5 out of 197 countries.
What is Canada's rank by Pharmaceutical spending per capita?
Canada ranks #5 out of 197 countries in the world ranking by «Pharmaceutical spending per capita».
How has Pharmaceutical spending per capita changed in Canada?
Over the available period the indicator changed from 350 to 950 $.